The EPS projection of Cognex Corporation (NASDAQ:CGNX) for quarter ended 2016-09-30 is $0.36. Last week, the EPS forecast was $0.36 against target of $0.36, a month earlier. Two months ago, this estimate was $0.36 versus forecast of $0.36 three months earlier, implying a deviation of 0%.
Cognex Corporation (NASDAQ:CGNX) stated that 18 days ago, its stock price was positively revised 2 times while negative revisions were 0.
In last week, the experts lowered EPS 0 times and increased EPS 0 times. In last 30, 120, 60 and 90 days, the experts upped revisions 0 , 2, 0, and 0, correspondingly.
EPS estimate downgrade for Cognex Corporation (NASDAQ:CGNX) in the preceding 30, 120, 60 and 90 days were 0, 3, 4, and 4, correspondingly.
Cognex Corporation (NASDAQ:CGNX) EPS target for the quarter closed 1 was $0.36, based on 5 recommendations. As reported on 2016-05-02 the EPS was $0.17. The change was $0.06, implying a percentage deviation of 54.55%. The projections showed a standard deviation of 0.01.
Quarterly Sales Estimates
Cognex Corporation (NASDAQ:CGNX) yearly sales prediction for the fiscal 2017 stands at $124.568 and the median estimate is at $124.568. Almost 2 analysts issued sales target.
Highest sales target is $125.9 while the lowest target is $123.236 showing standard deviation of 1.883%.
As many as 2 analysts have sales targets revised upside while 2 reduced sales estimates, implying a deviation of 0%.
Last month, 2 revised sales number projection on upside while 2 lowered the sales projections, implying a deviation of 1.714%.
A quarter ago, 2 hiked sales target and 2 reduced sales forecast. Cognex Corporation (NASDAQ:CGNX) announced that the deviation in forecast was -3.878%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...